Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
EV/Core EBITDA

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.7427.8634.9944.3827.87

What is the latest EV/Core EBITDA ratio of DR LAL PATHLABS ?

The latest EV/Core EBITDA ratio of DR LAL PATHLABS is 26.74 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.74
Mar202327.86
Mar202234.99
Mar202144.38
Mar202027.87

How is EV/Core EBITDA of DR LAL PATHLABS Trending?

Years EV/Core EBITDA % Change
Mar2024 26.74
-4.02
Mar2023 27.86
-20.38
Mar2022 34.99
-21.16
Mar2021 44.38
59.24
Mar2020 27.87 -

Other Financial Ratios of DR LAL PATHLABS


Compare EV/Core EBITDA ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹24,912.8 Cr 0.2% -3.3% 15% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹98,334.3 Cr 3.5% 0.6% 27.9% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹95,006.5 Cr 1.7% 7.3% 59.9% Stock Analytics
FORTIS HEALTHCARE ₹49,098.7 Cr -5.2% 10.6% 81.8% Stock Analytics
GLOBAL HEALTH ₹28,904.0 Cr 0.4% 1.5% 23.1% Stock Analytics
NARAYANA HRUDAYALAYA ₹25,517.5 Cr 0.3% 2.1% 1.4% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

0.2%

-3.3%

15%

SENSEX

2.5%

-0.5%

19.7%


You may also like the below Video Courses